Glutamate receptor-mediated mechanisms in levodopa-induced motor fluctuations in an experimental model of parkinsonism.
Marin
C
C
Laboratori de Neurologia Experimental, Universitat de Barcelona, Spain.
Tolosa
E
E
D000818:Animals; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology*; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D010302:Parkinson Disease, Secondary / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011810:Quinoxalines / Q000627:therapeutic use; D051381:Rats; D017207:Rats, Sprague-Dawley; D017470:Receptors, Glutamate / Q000502:physiology*; D012399:Rotation; D013239:Stereotyped Behavior / Q000187:drug effects / Q000502:physiology; D013997:Time Factors
D018691:Excitatory Amino Acid Antagonists; D010879:Piperazines; D011810:Quinoxalines; D017470:Receptors, Glutamate; C062865:2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline; D007980:Levodopa; C050592:3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid